Gene · 406950
Papers1,777
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,777
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34+ Cells from Sickle Cell Disease Patients. | Viruses | 2022 | 36560719 | PubTator, text mining | PubMed |
| The Molecular Mechanisms and Function of miR-15a/16 Dysregulation in Fibrotic Diseases. | Int J Mol Sci | 2022 | 36555676 | PubTator, text mining | PubMed |
| Contribution of Non-Coding RNAs to Anticancer Effects of Dietary Polyphenols: Chlorogenic Acid, Curcumin, Epigallocatechin-3-Gallate, Genistein, Quercetin and Resveratrol. | Antioxidants (Basel) | 2022 | 36552560 | PubTator, text mining | PubMed |
| MicroRNA29B induces fetal hemoglobin via inhibition of the HBG repressor protein MYB in vitro and in humanized sickle cell mice. | Front Med (Lausanne) | 2022 | 36507536 | PubTator, text mining | PubMed |
| The microRNA Lifecycle in Health and Cancer. | Cancers (Basel) | 2022 | 36497229 | PubTator, text mining | PubMed |
| Assessing the expression of two post-transcriptional BDNF regulators, TTP and miR-16 in the peripheral blood of patients with Schizophrenia. | BMC Psychiatry | 2022 | 36476595 | PubTator, text mining | PubMed |
| Consequences of genetic variants in miRNA genes. | Comput Struct Biotechnol J | 2022 | 36467588 | PubTator, text mining | PubMed |
| Circulating miR-326 could serve as a predictive biomarker for response to neoadjuvant chemotherapy in locally advanced cervical cancer. | Front Oncol | 2022 | 36439477 | PubTator, text mining | PubMed |
| Mechanisms and Outcomes of Metabolic Surgery in Type 2 Diabetes. | Metabolites | 2022 | 36422274 | PubTator, text mining | PubMed |
| A reproducible experimental survey on biomedical sentence similarity: A string-based method sets the state of the art. | PLoS One | 2022 | 36409715 | PubTator, text mining | PubMed |
| microRNAs associated with the pathogenesis and their role in regulating various signaling pathways during Mycobacterium tuberculosis infection. | Front Cell Infect Microbiol | 2022 | 36389170 | PubTator, text mining | PubMed |
| miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential. | Front Pharmacol | 2022 | 36386184 | PubTator, text mining | PubMed |
| Diagnostic and Therapeutic Implications of Long Non-Coding RNAs in Leukemia. | Life (Basel) | 2022 | 36362925 | PubTator, text mining | PubMed |
| Metformin Prevents Endothelial Dysfunction in Endometriosis through Downregulation of ET-1 and Upregulation of eNOS. | Biomedicines | 2022 | 36359302 | PubTator, text mining | PubMed |
| The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective. | Cancers (Basel) | 2022 | 36358746 | PubTator, text mining | PubMed |
| Circulating microRNA Related to Cardiometabolic Risk Factors for Metabolic Syndrome: A Systematic Review. | Metabolites | 2022 | 36355127 | PubTator, text mining | PubMed |
| A review on the role of mir-16-5p in the carcinogenesis. | Cancer Cell Int | 2022 | 36348403 | PubTator, text mining | PubMed |
| Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target. | Mol Cell Oncol | 2022 | 36313480 | PubTator, text mining | PubMed |
| Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential. | Front Immunol | 2022 | 36300115 | PubTator, text mining | PubMed |
| Predicting miRNA-disease associations based on multi-view information fusion. | Front Genet | 2022 | 36238163 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406950/papers?page=7